Abbott Laboratories's CEO Salary
- Philip P. Boudreau , Executive Vice President, Finance and Chief Financial Officer at Abbott Laboratories, received a total compensation of $9.09 M in 2025.
- Hubert L. Allen , Former Executive Vice President, General Counsel and Secretary at Abbott Laboratories, received a total compensation of $7.00 M in 2025.
- Christopher J. Scoggins , Executive Vice President, Diabetes Care at Abbott Laboratories, received a total compensation of $6.60 M in 2025.
- Daniel G. Salvadori , Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products at Abbott Laboratories, received a total compensation of $6.53 M in 2025.
Abbott Laboratories's CEO salary and other executives compensation in 2025 was as follows:
Executive Compensation Summary Table
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Philip P. Boudreau , Executive Vice President, Finance and Chief Financial Officer | $9.09 M | $8.23 M | $3.32 M |
| Base Salary | $974.23 K | $884.04 K | $513.94 K |
| Incentive Plan Compensation | $1.06 M | $1.22 M | $583.50 K |
| All Other Compensation | $968.72 K | $730.60 K | $647.43 K |
| Stock Award | $3.05 M | $2.69 M | $786.04 K |
| Hubert L. Allen , Former Executive Vice President, General Counsel and Secretary | $7.00 M | $7.98 M | $7.42 M |
| Base Salary | $524.02 K | $911.15 K | $830.00 K |
| Incentive Plan Compensation | $447.50 K | $1.09 M | $941.70 K |
| All Other Compensation | $1.83 M | $1.78 M | $1.73 M |
| Stock Award | $2.10 M | $2.10 M | $1.96 M |
| Christopher J. Scoggins , Executive Vice President, Diabetes Care | $6.60 M | - | - |
| Base Salary | $859.50 K | - | - |
| Incentive Plan Compensation | $1.10 M | - | - |
| All Other Compensation | $1.32 M | - | - |
| Stock Award | $1.66 M | - | - |
| Daniel G. Salvadori , Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products | $6.53 M | $5.79 M | $5.93 M |
| Base Salary | $924.23 K | $879.27 K | $790.00 K |
| Incentive Plan Compensation | $388.20 K | $855.40 K | $880.30 K |
| All Other Compensation | $744.02 K | $388.36 K | $503.85 K |
| Stock Award | $2.24 M | $1.83 M | $1.88 M |
| Robert B. Ford , Chairman of the Board and Chief Executive Officer | - | $22.78 M | $23.27 M |
| Base Salary | - | $1.50 M | $1.50 M |
| Incentive Plan Compensation | - | $2.86 M | $2.95 M |
| All Other Compensation | - | $1.96 M | $3.95 M |
| Stock Award | - | $8.23 M | $7.44 M |
| Robert B. Ford, Chairman of the Board and Chief Executive Officer | - | $22.78 M | $23.27 M |
| Base Salary | - | $1.50 M | $1.50 M |
| Incentive Plan Compensation | - | $2.86 M | $2.95 M |
| All Other Compensation | - | $1.96 M | $3.95 M |
| Stock Award | - | $8.23 M | $7.44 M |
| Robert E. Funck, Jr. Former Executive Vice President, Finance | - | $8.26 M | $8.99 M |
| Base Salary | - | $535.10 K | $875.00 K |
| Incentive Plan Compensation | - | $564.00 K | $1.06 M |
| All Other Compensation | - | $1.42 M | $1.87 M |
| Stock Award | - | $2.87 M | $2.59 M |
| Philip P. Boudreau, Executive Vice President, Finance and Chief Financial Officer | - | $8.23 M | $3.32 M |
| Base Salary | - | $884.04 K | $513.94 K |
| Incentive Plan Compensation | - | $1.22 M | $583.50 K |
| All Other Compensation | - | $730.60 K | $647.43 K |
| Stock Award | - | $2.69 M | $786.04 K |
| Hubert L. Allen, Executive Vice President, General Counsel and Secretary | - | $7.98 M | $7.42 M |
| Base Salary | - | $911.15 K | $830.00 K |
| Incentive Plan Compensation | - | $1.09 M | $941.70 K |
| All Other Compensation | - | $1.78 M | $1.73 M |
| Stock Award | - | $2.10 M | $1.96 M |
| Lisa D. Earnhardt , Executive Vice President and Group President, Medical Devices | - | $6.56 M | $5.50 M |
| Base Salary | - | $879.27 K | $737.65 K |
| Incentive Plan Compensation | - | $1.25 M | $904.90 K |
| All Other Compensation | - | $396.65 K | $487.21 K |
| Stock Award | - | $2.02 M | $1.68 M |
| Lisa D. Earnhardt, Executive Vice President and Group President, Medical Devices | - | $6.56 M | $5.50 M |
| Base Salary | - | $879.27 K | $737.65 K |
| Incentive Plan Compensation | - | $1.25 M | $904.90 K |
| All Other Compensation | - | $396.65 K | $487.21 K |
| Stock Award | - | $2.02 M | $1.68 M |
| Daniel G. Salvadori, Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products | - | $5.79 M | $5.93 M |
| Base Salary | - | $879.27 K | $790.00 K |
| Incentive Plan Compensation | - | $855.40 K | $880.30 K |
| All Other Compensation | - | $388.36 K | $503.85 K |
| Stock Award | - | $1.83 M | $1.88 M |
| Robert E. Funck, Jr., Executive Vice President, Finance | - | - | $8.99 M |
| Base Salary | - | - | $875.00 K |
| Incentive Plan Compensation | - | - | $1.06 M |
| All Other Compensation | - | - | $1.87 M |
| Stock Award | - | - | $2.59 M |
| Philip P. Boudreau, Senior Vice President, Finance and Chief Financial Officer | - | - | $3.32 M |
| Base Salary | - | - | $513.94 K |
| Incentive Plan Compensation | - | - | $583.50 K |
| All Other Compensation | - | - | $647.43 K |
| Stock Award | - | - | $786.04 K |
